0.8307
price down icon3.62%   -0.0312
after-market Dopo l'orario di chiusura: .84 0.0093 +1.12%
loading
Precedente Chiudi:
$0.8619
Aprire:
$0.852
Volume 24 ore:
642.51K
Relative Volume:
0.85
Capitalizzazione di mercato:
$79.31M
Reddito:
$169.43M
Utile/perdita netta:
$-186.01M
Rapporto P/E:
-0.4112
EPS:
-2.02
Flusso di cassa netto:
$70.07M
1 W Prestazione:
-2.28%
1M Prestazione:
-10.98%
6M Prestazione:
-48.08%
1 anno Prestazione:
-9.52%
Intervallo 1D:
Value
$0.818
$0.8625
Intervallo di 1 settimana:
Value
$0.818
$0.9391
Portata 52W:
Value
$0.7324
$1.798

Assertio Holdings Inc Stock (ASRT) Company Profile

Name
Nome
Assertio Holdings Inc
Name
Telefono
(224) 419-7106
Name
Indirizzo
100 S. SAUNDERS ROAD, LAKE FOREST, IL
Name
Dipendente
30
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
ASRT's Discussions on Twitter

Confronta ASRT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
ASRT
Assertio Holdings Inc
0.8307 79.31M 169.43M -186.01M 70.07M -2.02
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
165.02 74.45B 9.15B 2.43B 2.31B 5.32
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.49 42.91B 14.26B 1.55B 0 0.3383
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.24 41.98B 30.27B 1.93B 3.45B 0.6044
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
21.49 24.35B 16.77B -959.00M 1.37B -0.85
Drug Manufacturers - Specialty & Generic icon
VTRS
Viatris Inc
11.96 14.28B 15.05B -883.30M 1.89B -0.74

Assertio Holdings Inc Stock (ASRT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-07-26 Iniziato Maxim Group Buy
2024-07-03 Iniziato H.C. Wainwright Buy
2022-11-07 Iniziato Lake Street Buy
2018-11-30 Downgrade Mizuho Buy → Neutral

Assertio Holdings Inc Borsa (ASRT) Ultime notizie

pulisher
Jan 03, 2025

Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - The Manila Times

Jan 03, 2025
pulisher
Jan 03, 2025

Assertio Holdings Names New Chief Commercial Officer, Awards Major Stock Incentive Package - StockTitan

Jan 03, 2025
pulisher
Jan 02, 2025

Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of Illinois against Assertio Holdings, Inc. - AccessWire

Jan 02, 2025
pulisher
Dec 31, 2024

Assertio Holdings, Inc. (NASDAQ:ASRT) Short Interest Up 14.1% in December - MarketBeat

Dec 31, 2024
pulisher
Dec 24, 2024

Is Assertio Holdings (NASDAQ:ASRT) A Risky Investment? - Simply Wall St

Dec 24, 2024
pulisher
Dec 18, 2024

Assertio appoints new independent director to board By Investing.com - Investing.com South Africa

Dec 18, 2024
pulisher
Dec 17, 2024

Assertio appoints new independent director to board - Investing.com

Dec 17, 2024
pulisher
Dec 17, 2024

Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors - The Manila Times

Dec 17, 2024
pulisher
Dec 17, 2024

Assertio Holdings Taps Former Astellas President Who Led $5B Sales Growth to Join Board - StockTitan

Dec 17, 2024
pulisher
Dec 17, 2024

Assertio’s (ASRT) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

Dec 17, 2024
pulisher
Dec 16, 2024

Assertio Therapeutics shares get buy rating on clinical trial results By Investing.com - Investing.com Canada

Dec 16, 2024
pulisher
Dec 16, 2024

Assertio (NASDAQ:ASRT) Receives Buy Rating from HC Wainwright - MarketBeat

Dec 16, 2024
pulisher
Dec 15, 2024

Assertio Holdings, Inc. (NASDAQ:ASRT) Short Interest Down 11.5% in November - MarketBeat

Dec 15, 2024
pulisher
Dec 14, 2024

Assertio reports positive Rolvedon trial results for breast cancer By Investing.com - Investing.com Australia

Dec 14, 2024
pulisher
Dec 13, 2024

Assertio Announces Results of Rolvedon (Eflapegrastim-Xnst) Injection Same-Day Dosing Clinical Study - Marketscreener.com

Dec 13, 2024
pulisher
Dec 13, 2024

Assertio reports positive Rolvedon trial results for breast cancer - Investing.com

Dec 13, 2024
pulisher
Dec 13, 2024

Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study - The Manila Times

Dec 13, 2024
pulisher
Dec 12, 2024

Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCO - The Manila Times

Dec 12, 2024
pulisher
Dec 12, 2024

Assertio Holdings Creates Transformation Office, Appoints New Leadership to Drive Growth Strategy - StockTitan

Dec 12, 2024
pulisher
Dec 06, 2024

Assertio Holdings Inc (NASDAQ: ASRT): Blank Check On Growth? - Stocks Register

Dec 06, 2024
pulisher
Dec 06, 2024

Beam Therapeutics Announces Appointment of Sravan Emany as Chief Financial Officer - GlobeNewswire Inc.

Dec 06, 2024
pulisher
Dec 06, 2024

Beam Therapeutics names Sravan K. Emany as new CFO - Investing.com

Dec 06, 2024
pulisher
Nov 28, 2024

HC Wainwright Forecasts Stronger Earnings for Assertio - MarketBeat

Nov 28, 2024
pulisher
Nov 25, 2024

Assertio shares hold price target, buy rating on stable Indocin share By Investing.com - Investing.com Canada

Nov 25, 2024
pulisher
Nov 25, 2024

Assertio Holdings, Inc. (NASDAQ:ASRT) Shares Acquired by Empowered Funds LLC - Defense World

Nov 25, 2024
pulisher
Nov 20, 2024

Assertio Holdings Q3 2024 Earnings Preview - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Assertio stock gains amid Q3 earnings, clash with activist investor - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

Insider Buying: Assertio Holdings, Inc. (NASDAQ:ASRT) Director Acquires $60,000.00 in Stock - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Assertio Holdings director Heather Mason buys $60,000 in shares By Investing.com - Investing.com Nigeria

Nov 19, 2024
pulisher
Nov 19, 2024

Assertio Holdings director Heather Mason buys $60,000 in shares - Investing.com

Nov 19, 2024
pulisher
Nov 15, 2024

Assertio Holdings CEO Brendan O'Grady buys $9,950 in common stock - Investing.com India

Nov 15, 2024
pulisher
Nov 15, 2024

Spectrum Pharma Faces Senate Probe Call Over Alleged Rolvedon Data Fraud | ASRT Stock News - StockTitan

Nov 15, 2024
pulisher
Nov 14, 2024

Assertio Holdings Inc (ASRT) Quarterly 10-Q Report - Quartz

Nov 14, 2024
pulisher
Nov 13, 2024

Assertio Holdings Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St

Nov 13, 2024
pulisher
Nov 12, 2024

Assertio Holdings, Inc. (NASDAQ:ASRT) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 12, 2024
pulisher
Nov 12, 2024

Assertio Reports Third Quarter 2024 Financial Results - The Manila Times

Nov 12, 2024
pulisher
Nov 12, 2024

Assertio: Q3 Earnings Snapshot - The Washington Post

Nov 12, 2024
pulisher
Nov 11, 2024

Assertio Therapeutics’ Q3 2024 Earnings Overview - TipRanks

Nov 11, 2024
pulisher
Nov 11, 2024

Assertio stock gains amid Q3 earnings, clash with activist investor (NASDAQ:ASRT) - Seeking Alpha

Nov 11, 2024
pulisher
Nov 11, 2024

Assertio (ASRT) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance

Nov 11, 2024
pulisher
Nov 11, 2024

Assertio Holdings, Inc. Announces Board Changes - Marketscreener.com

Nov 11, 2024
pulisher
Nov 11, 2024

Assertio Holdings Faces SEC Whistleblower Complaint Over Alleged Clinical Data Fraud | ASRT Stock News - StockTitan

Nov 11, 2024
pulisher
Nov 11, 2024

Assertio Provides Response to Letter from Short-seller - GlobeNewswire

Nov 11, 2024
pulisher
Nov 11, 2024

Assertio Holdings CEO Fires Back at Short-Seller's 'Baseless' Rolvedon Claims | ASRT Stock News - StockTitan

Nov 11, 2024
pulisher
Nov 09, 2024

Assertio Holdings (NASDAQ:ASRT investor five-year losses grow to 72% as the stock sheds US$17m this past week - Simply Wall St

Nov 09, 2024
pulisher
Nov 08, 2024

Assertio faces fraud claims, investor goes short on stock By Investing.com - Investing.com India

Nov 08, 2024
pulisher
Nov 08, 2024

Assertio Stock Alert: Major Investor Warns of Fraud Claims, Safety Issues in Spectrum Deal | ASRT Stock News - StockTitan

Nov 08, 2024
pulisher
Nov 08, 2024

Assertio Holdings Inc (ASRT) Q3 2024: Everything You Need to Know Ahead of Earnings - Yahoo Finance

Nov 08, 2024

Assertio Holdings Inc Azioni (ASRT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$11.55
price down icon 2.12%
$94.00
price down icon 3.01%
$82.56
price down icon 0.80%
drug_manufacturers_specialty_generic RDY
$15.81
price up icon 0.89%
$138.71
price up icon 0.84%
$11.96
price down icon 0.33%
Capitalizzazione:     |  Volume (24 ore):